Cuvitru 00944-2850
Generic: Immune Globulin Subcutaneous (human)
Product NDC
00944-2850- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Plasma Derivative
- Marketing Start
- October 18, 2016
- Listing Expires
- December 31, 2026
- Application
- BLA125596
Active Ingredients
| Ingredient | Strength |
|---|---|
| Human Immunoglobulin G | 200 mg/mL |
Drug Class
Antigen Neutralization [MoA]Human Immunoglobulin G [EPC]Immunoglobulins [CS]
Packaging Options(5)
1 VIAL, SINGLE-USE in 1 CARTON (0944-2850-01) / 5 mL in 1 VIAL, SINGLE-USE (0944-2850-02)
1 VIAL, SINGLE-USE in 1 CARTON (0944-2850-03) / 10 mL in 1 VIAL, SINGLE-USE (0944-2850-04)
1 VIAL, SINGLE-USE in 1 CARTON (0944-2850-05) / 20 mL in 1 VIAL, SINGLE-USE (0944-2850-06)
1 VIAL, SINGLE-USE in 1 CARTON (0944-2850-07) / 40 mL in 1 VIAL, SINGLE-USE (0944-2850-08)
1 BOTTLE, GLASS in 1 CARTON (0944-2850-09) / 50 mL in 1 BOTTLE, GLASS (0944-2850-10)